A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer TherapyShintaro Taki(National Institute of Biomedical Innovation, Health and Nutrition), Shin‐ichi Tsunoda(Kobe Gakuin University)PLoS ONEDecember 17, 201510.1371/journal.pone.0144712Cited by 44SaveCiteExport RISWatch citationsRelated PapersBivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells|Scientific Reports|2023|14